TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TELA Bio ( (TELA) ) has issued an announcement.
On October 31, 2025, TELA Bio, Inc. expanded its Board of Directors from six to seven members by appointing William Plovanic as a Class I director, with his term set to expire at the 2026 Annual Meeting of Stockholders. Mr. Plovanic, with extensive experience in healthcare equity research and leadership roles in medical technology companies, is expected to bring valuable insights to TELA Bio. His appointment, accompanied by an initial equity award, aligns with the company’s non-employee director compensation policy, potentially enhancing TELA Bio’s strategic direction and governance.
The most recent analyst rating on (TELA) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on TELA Bio stock, see the TELA Stock Forecast page.
Spark’s Take on TELA Stock
According to Spark, TipRanks’ AI Analyst, TELA is a Underperform.
TELA Bio’s overall stock score is primarily impacted by its financial performance and technical analysis. Despite revenue growth, the company faces significant profitability challenges, reflected in its negative P/E ratio and cash flow issues. The technical indicators suggest a bearish trend, further weighing down the score. The earnings call highlighted positive revenue growth, but this was not enough to offset the financial and technical challenges.
To see Spark’s full report on TELA stock, click here.
More about TELA Bio
TELA Bio, Inc. operates in the medical technology industry, focusing on developing and commercializing soft tissue reconstruction solutions. The company primarily targets the healthcare sector with its innovative products designed to improve patient outcomes.
Average Trading Volume: 98,533
Technical Sentiment Signal: Strong Sell
Current Market Cap: $48.73M
Find detailed analytics on TELA stock on TipRanks’ Stock Analysis page.